← Companies
DYNAVAX TECHNOLOGIES CORP
Data as of Sep 17, 2026
DVAX
CIK 1029142Reported federal lobbying
$1.4M
14 filings · latest Jul 20, 2026
Federal contracts since 2024
$1.1M
3 awards · latest Sep 22, 2025
Lobbying
$1,385,000 in reported federal lobbying spend across 14 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Pharmacy$525K7 filings
Latest filings, Jan 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES Pharmacy Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA) | $75,000 |
| Jul 17, 2026 | DYNAVAX TECHNOLOGIES CORP. Unspecified | $120,000 |
| Apr 23, 2026 | RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES Pharmacy Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA) | $75,000 |
| Apr 20, 2026 | DYNAVAX TECHNOLOGIES CORP. Unspecified | $120,000 |
| Jan 18, 2026 | RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES Pharmacy Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA) | $75,000 |
| Jan 17, 2026 | DYNAVAX TECHNOLOGIES CORP. Unspecified | $120,000 |